$118.73 📈 (+2.52 / +2.17%) as of May 8, 2025, 4:10 PM ET
Ticker: KKR
Tagline: If it makes money, we’ll buy it. 💼💸

💥 Trigger Warning: Insider Confidence Detected

On May 6th, Director Robert W. Scully whipped out $1.5 million to scoop up 13,250 shares at $113.49. That’s not a nibble—that’s a fork-and-knife sit-down meal of KKR stock. 🍽️

🧠 Insider takeaway? Mr. Scully didn’t just tiptoe in—he cannonballed.

📦 What Even Is KKR?

A better question: What isn’t KKR?
This is a firm that invests in:

🏗️ Infrastructure, 🧬 biotech, 🛒 grocery stores, 🎬 media, ⚡ energy, 📡 cybersecurity, 🧥 luxury fashion, and yes—even 🧃juice companies (probably).

They specialize in:

• Buyouts

• Growth equity

• Mezzanine lending

• Turnarounds

• Anything that breathes revenue

🎯 From IoT to port logistics, if it has a pulse (or a yield), KKR has a stake.

🧠 Who’s Backing KKR?

Oh, just some small-timers like:

And insiders? They own nearly 24% of the company. 🤝

Check this out for more.

📊 Recent Performance: Just Another Billion-Dollar Quarter

Q1 2025 Highlights:

• 🧾 Fee-Related Earnings: $823M this quarter (+23% YoY)

• 🧠 Adjusted Net Income: $1.0B this quarter (+20% YoY)

• 🏦 Assets Under Management: $664B (+15% YoY)

• 💼 Capital Raised: $114B in the last 12 months

• 💥 Capital Invested: $88B in the last 12 months

• 💰 Dividend: $0.185 per quarter (+6% YoY, yield under 1%)

• 💸 Share Buybacks: $107M so far this year, with a new $500M plan in motion

That’s a lot of commas. 💵💵💵

🚦But Wait—Is It Too Pricey?

• Trailing P/E: 36.20 😬

• Forward P/E: 21.84 😌

Sure, it ain’t cheap-cheap. But for a growing beast with proven performance and scale? It’s not outrageous either.

Think of it like this: you're paying up for quality, but at least it’s not luxury yogurt levels of overpriced.

Interested in investing in another Wall Street powerhouse?
Check this out.

🧬 KKR’s Evolution: From Buyouts to Biotech

They’re no longer just a buyout firm. KKR is transforming:

• Then (2007–2015): Build the platform 🏗️

• Now (2016–2025): Scale it like a beast 🔥

  • Real estate ✅

  • Infrastructure ✅

  • Biotech (hello, Biotage!) ✅

  • Core strategies + growth engines ✅

They now do 200–400+ deals per year. That’s not a strategy—it’s a full-blown industrial machine. 🏭

⚠️ Risks? Always.

• 🎢 Market downturns = ouch

• 🧪 Complex portfolio = exposure

• 🤔 Scully might be clueless… except he’s not. With a resume that screams “Wall Street Hall of Fame” (Morgan Stanley, Lehman, Princeton, HBS, etc.), he knows a thing or two about capital allocation.

🧠 Verdict

💎 KKR is a gem—albeit not a hidden one.

• Strong earnings ✔️

• Shareholder-friendly ✔️

• Insider and institutional conviction ✔️

• Scalable model ✔️

Just don’t expect a moonshot. Expect compounding strength—the kind that builds empires.

😜 Usual Unusual Disclaimer

This isn’t financial advice. It’s entertainment. If you end up investing and KKR buys a cheese company that tanks, we never met.